Stockreport

Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026 [Yahoo! Finance]

Vyome Holdings, Inc.  (HIND) 
PDF CAMBRIDGE, Mass., April 06, 2026 BUSINESS WIRE )--Vyome Holdings, Inc. ("Vyome") (Nasdaq: HIND) today announced that the company will present its full Phase 2 investiga [Read more]